# Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA

> **NCT02922582** · PHASE2 · TERMINATED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 16 (actual)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** DepoTXA
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02922582
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-28
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Slow Enrollment
- **Last updated:** 2020-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922582, "Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02922582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*